nepafenac has been researched along with Retinal Perforations in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Addobbati, R; Agostinis, C; Cecchini, P; Cirigliano, G; D'Aloisio, R; De Giacinto, C; Di Martino, G; Di Nicola, M; Pastore, MR; Radillo, O; Tognetto, D | 1 |
1 trial(s) available for nepafenac and Retinal Perforations
Article | Year |
---|---|
VITREOUS PROSTAGLANDIN E2 CHANGES AFTER TOPICAL ADMINISTRATION OF DICLOFENAC 0.1%, INDOMETHACIN 0.5%, NEPAFENAC 0.3%, AND BROMFENAC 0.09.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Chromatography, High Pressure Liquid; Diclofenac; Dinoprostone; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Epiretinal Membrane; Female; Humans; Indomethacin; Male; Middle Aged; Ophthalmic Solutions; Phenylacetates; Prospective Studies; Retinal Perforations; Vitrectomy; Vitreous Body | 2020 |